Key Moments
The disaster I never imagined having to worry about
VeritasiumKey Moments
A critical HIV drug, Retonavir, unexpectedly transformed into a stable, undissolvable crystal form overnight, rendering it useless and threatening production worldwide.
Key Insights
Retonavir, which had a 2-year perfect record, suddenly failed dissolution tests due to a spontaneous crystallization into a new, more stable form named Form 2.
The unexpected crystallization of Retonavir was initially baffling, as all manufacturing parameters remained unchanged, yet production lines globally became contaminated within weeks.
The phenomenon mirrors the historical discovery of isomers by chemists Justus von Liebig and Friedrich Wöhler, who found compounds with identical elemental composition but different atomic arrangements and properties.
Chocolate's six polymorphs (crystal forms) illustrate how subtle changes in molecular stacking affect properties like melting point and texture, with Form 5 being the desired shiny, snappy state.
The 'tin pest' phenomenon, where tin transforms into a brittle gray form below 13°C, demonstrates how a stable polymorph can spontaneously arise and spread, initiating a cascading transformation.
Pharmaceutical companies now invest millions to screen for polymorphs, recognizing the unpredictable risks, but the Retonavir incident, though rare, highlighted that even known drugs could be lost.
Retonavir's miracle turns to disaster
Introduced in 1996, Retonavir was a life-saving HIV medication that transformed a death sentence into a manageable condition. For two years, 75,000 patients relied on up to 20 pills daily, with an uninterrupted record of 240 consecutive successful production lots. The process included rigorous quality control, with dissolution testers ensuring capsules dissolved within 30 minutes for proper absorption. However, this perfect record was shattered when an analyst observed a capsule fail to dissolve, triggering an emergency shutdown. The batch was destroyed, and the production line deep-cleaned. The next day, the same anomaly recurred: clear capsules turned white and cloudy, revealing millions of tiny needle-like crystals under a microscope. Attempts to replicate Retonavir in the lab, even with precise knowledge of its composition and manufacturing process, consistently yielded the cloudy, crystalline form, baffling scientists.
A global contagion of crystal failure
The problem escalated rapidly, with every tablet produced by the lab and factory turning cloudy within a week. Abbott, the manufacturer, was forced to halt production, but halting supply was not an option for the patients. They attempted to restart production at a facility in Italy, which initially succeeded. However, this success only deepened the mystery, implying a flaw in the Chicago production. Upon investigators' return from Italy, a call confirmed the worst: the Italian facility also began failing dissolution tests. Within five to six weeks, "every place the product was became contaminated with the crystals." The crisis was unprecedented: they couldn't detect it, test for it, understand its cause, or prevent it. This widespread, inexplicable transformation of a crucial medicine led to the realization that they were facing a rare disaster, a "disappearing polymorph" that could theoretically affect any drug or chemical compound, spreading like a disease and leaving its victims dependent on a medicine that could vanish overnight.
Echoes of a 170-year-old scientific feud
The mystery of Retonavir's transformation echoed a heated debate from 170 years prior between chemists Justus von Liebig and Friedrich Wöhler. Wöhler published findings on a new compound, but Liebig, a respected chemist, vehemently disagreed, calling Wöhler a "hopeless analyst." Their public dispute, marked by successive papers and a final meeting to replicate each other's work, culminated in a stunning revelation: both were correct. They had synthesized different compounds with the same elemental composition (one carbon, one nitrogen, one oxygen, one sulfur) but distinct structures and properties. Wöhler's compound was stable silver cyanate, while Liebig's was explosive silver fulminate. This discovery demonstrated that the arrangement of atoms, not just their types, fundamentally determined a compound's behavior, introducing the concept of isomers. This historical parallel suggested that Retonavir's crystallographic shift might be the key to its disaster.
Polymorphism: The many faces of a molecule
The scientists at Abbott suspected polymorphism might be at play. Polymorphism refers to a material's ability to exist in multiple crystal structures, each with different physical properties. Chocolate serves as a relatable example: its texture, shine, and melting point depend on how its cocoa butter molecules stack. Chocolate has six such crystal forms (polymorphs), with Form 5 being the desired shiny, snappy state. Achieving this requires precise control over temperature and time during tempering. Heating the chocolate to melt all crystals (around 45-50°C) and then cooling it to specific temperatures (around 34°C for Form 5 nucleation, then lower to encourage rapid nucleation) allows for the selection of the desired polymorph. This tempering process involves carefully managing the energy states and barriers between different forms, akin to a ball rolling down different valleys separated by hills.
Retonavir's crystal forms and their energy barriers
In Retonavir, the original, soluble form was designated Form 1, while the new, crystalline, undissolvable form was Form 2. Spectroscopic analysis confirmed that although Form 2 had the same bonds as Form 1, subtle changes in their arrangement created a more stable configuration. Like chocolate's polymorphs, these forms have different energy levels. Form 2 of Retonavir was significantly more stable than Form 1, meaning it had a lower energy state and was less soluble. The challenge was that the energy barrier between Form 1 and Form 2 was immense. While chocolate could be re-tempered by melting and recrystallizing, attempts to convert Retonavir's Form 2 back to Form 1 failed. The deeper energy "valley" of Form 2 meant it was virtually impossible to climb back out without immense energy input, trapping the drug in its unusable crystalline state.
Tin pest: A chilling parallel spreading the disaster
The question remained: why did Form 2 suddenly appear everywhere? The phenomenon mirrored "tin pest," observed centuries prior. Organ pipes made of tin would spontaneously transform into a brittle, gray form below 13°C, causing them to crack and disintegrate. This transformation occurs because gray tin is a different crystal structure, less dense and more prone to expansion. Normally, transforming silver tin to gray tin requires significant energy. However, once a tiny speck of gray tin forms, it acts as a nucleation site, dramatically lowering the activation energy needed for surrounding tin atoms to convert. This allows the gray tin to spread like an infectious disease. Similarly, in Retonavir, a single crystal of Form 2 acted as a seed, lowering the activation energy and causing the rapid conversion of all available Form 1 into Form 2.
Seeding the global contamination
The widespread presence of Form 2 was attributed to this seeding effect. Once a tiny amount of Form 2 appeared, it became a nucleation site, triggering broader crystallization. Small seed crystals could break off, become airborne, and contaminate clothing and surfaces, naturally spreading to other batches and production lines. This airborne seeding likely explains how the Chicago team unknowingly contaminated the Italian facility upon their visit. Even dust particles or scratches in manufacturing equipment could induce the formation of new crystal structures. This unpredictable seeding process meant that once a more stable form appeared, it could spread globally, making it incredibly difficult, if not impossible, to ever recover the original, desired polymorph.
The aftermath and lessons learned
After five months of intensive research, Abbott announced their findings, acknowledging the "scientific and chemical impossibility" of the transformation and admitting they were victims of unpredictable bad luck. They could not eliminate Form 2, so they shifted their focus to adapting to a "Form 2 world." Ultimately, they abandoned the semi-solid capsule form and reverted to an older, less ideal liquid formulation, which had worse side effects but was usable. The Retonavir incident, though rare, was a major red flag, prompting significant regulatory and scientific activity around polymorph screening. Pharmaceutical companies now invest substantial sums to identify and control polymorphs, recognizing the profound risk: a drug that works one day could vanish the next, with no guarantee that a safety net, like an alternative formulation, will always be available.
Mentioned in This Episode
●Software & Apps
●Companies
●Drugs & Medications
●People Referenced
Common Questions
The Retonavir drug failed its dissolution test because it transformed into a more stable crystal form, known as a polymorph (form two). This new form did not dissolve properly, rendering the medication ineffective.
Topics
Mentioned in this video
A prominent chemist who initially debated Friedrich Wohler's findings on silver cyanate, arguing that Wohler's results were incorrect, only to later discover they were both correct due to isomeric forms.
A chemist whose discovery of a compound was initially debated with Justus von Liebig, only for both to be proven correct about different forms of the same compound.
Quoted for his famous saying about compound interest being the eighth wonder of the world.
More from Veritasium
View all 96 summaries
22 minCan a quantum sensor detect your heartbeat from 60 km away?
27 minCan you steal $10,000 from a locked iPhone?
59 minWhy Is CERN Making Antimatter?
29 minThe Secret Spy Tech Inside Every Credit Card
Ask anything from this episode.
Save it, chat with it, and connect it to Claude or ChatGPT. Get cited answers from the actual content — and build your own knowledge base of every podcast and video you care about.
Get Started Free